YOU ARE HERE:
Latest news
page  of 223
 
Headline
Date
  Concerns over miscarriage of justice after first UK conviction for transmission of hepatitis B
21.11.08
  Slow progress to expand rountine HIV testing in the US
21.11.08
  Excellent outcomes from five years of antiretroviral use in Botswana
20.11.08
  CD4 cell count increases sustained up to five years in developing-world treatment programmes
20.11.08
  Raltegravir may have role in PEP if exposure involves drug-resistant HIV
20.11.08
  High rate of death amongst patients with HIV diagnosed late
20.11.08
  Study explores verbal and non-verbal communication in unprotected sex between men
18.11.08
  IL-2 provides quick ‘AIDS rescue’, but effect does not always last
17.11.08
  Once-a-day etravirine should work as first-line treatment
16.11.08
  Second-line combinations fail twice as often as first-line ones in the first year
16.11.08
  If you can't switch, better to stay on failing treatment than stop it, studies show
14.11.08
  HIV treatment safe and effective in South African patients with hepatitis B co-infection, but co-infection frequent
13.11.08
  Non-nucleoside resistance is efficiently transmitted within infection ‘clusters’
13.11.08
  One in five Kenyan patients suffers major interactions with HIV drugs
13.11.08
  Almost half of Africans with HIV in UK are diagnosed late
12.11.08
  South African resistance survey confirms that clade C is more likely to develop multi-drug resistance mutation
12.11.08
  Treatment breaks set for a come-back?
12.11.08
  Adenovirus-based T-cell vaccine prevents AIDS in monkeys, offering fresh hope for approach
11.11.08
  Why are gay men reluctant to test for HIV?
07.11.08
  Modern HIV treatment can work well with adherence below 95%
07.11.08

page  of 223